BiotechTube
Home/Pipeline/TASCENSO ODT

TASCENSO ODT

Not specified

ApprovedActive

Key Facts

Indication
Not specified
Phase
Approved
Status
Active
Company
Handa Pharmaceuticals

About Handa Pharmaceuticals

Handa Pharma is a private, U.S.-based specialty and generic drug company operating in a commercial stage with an approved product portfolio. Its business model centers on in-licensing, developing, and commercializing complex generic and specialty therapeutics, as evidenced by its partnered products like PHYRAGO and TASCENSO ODT. The company is led by an experienced team with a track record of building successful pharmaceutical businesses. Handa's strategy appears to focus on identifying niche opportunities within the generic drug market to provide patient-friendly alternatives.

View full company profile

Other Not specified Drugs

DrugCompanyPhase
FL116Forlong BiotechnologyNot specified
FL117Forlong BiotechnologyNot specified
FL118Forlong BiotechnologyNot specified
FL301Forlong BiotechnologyNot specified
JSKN016AlphaMab OncologyPhase 1
JSKN033AlphaMab OncologyPhase 1
JSKN022AlphaMab OncologyPhase 1
JSKN027AlphaMab OncologyPhase 1
KN019AlphaMab OncologyPhase 1
New TCM FormulationsChina SXT PharmaceuticalsResearch / Pre-clinical
Long-acting LeronlimabCytoDynPreclinical
SR2162SIMR (Australia) BiotechIND Approved